While a number of biopharma companies have launched efforts to address the sparse number of women in high-ranking positions, there’s still much work to be done. In our 3rd annual Women in Biopharma R&D report, Endpoints News continues its celebration of women who are blazing trails in drug research and leaving lasting marks for others to follow.
Join us this December as we honor a group of 20 extraordinary women who are making lasting impacts in the drug development field — and for the second time, we’re bringing their stories to a live virtual audience.
see the honoreesEven though studies suggest that women are entering the biopharma field at similar rates as men, it’s far less likely that they go on to hold high-ranking positions, especially in R&D. At Endpoints News, we believe it’s important to honor the women who have beaten those odds, and paved the way for others to follow.
We are excited to introduce you to this year’s group of 20 honorees and hope you find their stories as inspiring as we do. And we’ve included a selection of video clips from our interviews to help provide a cross-section of their thoughts on the subject.
Calls to diversify the biopharma industry have grown louder over the last year, and in response, more companies have made laudable efforts to address the issue. We’ll sit down with four leaders from across the biopharma industry to discuss breaking the glass ceiling, the limitations of existing gender diversity programs, and what comes next.